Population pharmacokinetic–pharmacodynamic model of elinzanetant based on integrated clinical phase I and II data by Stefan Willmann, Adam Lloyd, Rupert Austin, Shiju Joseph, Alexander Solms, Yang Zhang, Annika R. P. Schneider, Sebastian Frechen, Marcus‐Hillert Schultze‐Mosgau

Get full text